Equity Profile

SBRA

Sabra Health Care REIT, Inc.

Real EstateHealth Care REITs$5.1B

Aug3Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Sabra Health Care REIT, Inc. is a real estate investment trust that focuses on acquiring and managing healthcare-related properties....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and will show how well Sabra is managing its healthcare properties.

0.17

Revenue

Total revenue gives insight into the company's overall performance and growth in the healthcare real estate market.

219M

Wall Street expectations, options signals, track record, and call prep available with Pro.

SBRA Q2-2026 Earnings Preview

Context

Company Snapshot

Sabra Health Care REIT, Inc. is a real estate investment trust that focuses on acquiring and managing healthcare-related properties. With a market cap of $5 billion, it plays a vital role in the healthcare sector by providing capital to operators of skilled nursing and other healthcare facilities.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+1.53%

Avg Stock Reaction

+0.54%

Last Quarter Recap

In Q1-2026, Sabra reported an EPS of $0.37, slightly missing the estimate of $0.38. The stock reacted negatively, dropping 0.78% the following day.

Management Promises & Guidance

Focus on improving occupancy rates in their facilities.
Commitment to maintaining dividend payouts.
Plans to explore new acquisition opportunities in the healthcare sector.

Expectations

Wall Street Expectations

Analysts expect Sabra to report modest earnings this quarter, with a consensus EPS of $0.17 and revenue of $219 million. The market is watching closely for any signs of recovery in occupancy rates.

Bull Case

If Sabra can exceed EPS expectations and show strong revenue growth, it could signal a rebound in the healthcare real estate market, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it could raise concerns about its ability to navigate the current economic environment.

Key Metrics to Watch

EPS

0.17

Earnings per share is a key indicator of the company's profitability and will show how well Sabra is managing its healthcare properties.

Revenue

219M

Total revenue gives insight into the company's overall performance and growth in the healthcare real estate market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will occupancy rates improve compared to last quarter?

Occupancy rates are crucial for revenue generation in Sabra's properties, and any improvement could indicate a positive trend.

What is the outlook for new acquisitions in the healthcare sector?

Investors will be keen to understand management's strategy for growth, particularly in a competitive real estate market.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Sabra to improve occupancy rates as the healthcare sector stabilizes post-pandemic.

Supporting Evidence

Recent trends in healthcare demand suggest a rebound in occupancy rates.

Options pricing indicates higher volatility, which could reflect investor uncertainty that may not be justified.

Sabra's strategic focus on acquisitions could position it well for growth despite current challenges.

Key Risk

If occupancy rates show a significant improvement, it could shift the market's perception of Sabra's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Sabra can recover from recent earnings misses and capitalize on growth opportunities in healthcare real estate.

Bull Confirmed If

Exceeding EPS of $0.17 and showing revenue growth above $219 million would confirm the bull case.

Bear Confirmed If

Falling short of the $0.17 EPS estimate and showing declining revenue would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±12.32%

Historical Avg

±1.2%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings announcement.

Options are pricing ±12.3% while SBRA has averaged ±1.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

19.8%

Calls (800)P/C Ratio: 0.18Puts (100)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Sabra beats expectations, history suggests the stock could rise by about 0.37%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating an average drop of 0.71% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on occupancy rates and any changes in tenant demand.
2Details on potential acquisitions or partnerships in the healthcare sector.
3Management's outlook on the healthcare market and economic conditions.
4Any changes to dividend policies or financial guidance.
5Insights into operational efficiencies and cost management strategies.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Sabra Health Care REIT, Inc. is a real estate investment trust that focuses on acquiring and managing healthcare-related properties....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and will show how well Sabra is managing its healthcare properties.

0.17

Revenue

Total revenue gives insight into the company's overall performance and growth in the healthcare real estate market.

219M

Wall Street expectations, options signals, track record, and call prep available with Pro.

SBRA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+1.53%

Avg Stock Reaction

+0.54%

Last Quarter Recap

In Q1-2026, Sabra reported an EPS of $0.37, slightly missing the estimate of $0.38. The stock reacted negatively, dropping 0.78% the following day.

Management Promises & Guidance

Focus on improving occupancy rates in their facilities.
Commitment to maintaining dividend payouts.
Plans to explore new acquisition opportunities in the healthcare sector.

Expectations

Wall Street Expectations

Analysts expect Sabra to report modest earnings this quarter, with a consensus EPS of $0.17 and revenue of $219 million. The market is watching closely for any signs of recovery in occupancy rates.

Bull Case

If Sabra can exceed EPS expectations and show strong revenue growth, it could signal a rebound in the healthcare real estate market, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it could raise concerns about its ability to navigate the current economic environment.

Key Metrics to Watch

EPS

0.17

Earnings per share is a key indicator of the company's profitability and will show how well Sabra is managing its healthcare properties.

Revenue

219M

Total revenue gives insight into the company's overall performance and growth in the healthcare real estate market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will occupancy rates improve compared to last quarter?

Occupancy rates are crucial for revenue generation in Sabra's properties, and any improvement could indicate a positive trend.

What is the outlook for new acquisitions in the healthcare sector?

Investors will be keen to understand management's strategy for growth, particularly in a competitive real estate market.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Sabra to improve occupancy rates as the healthcare sector stabilizes post-pandemic.

Supporting Evidence

Recent trends in healthcare demand suggest a rebound in occupancy rates.

Options pricing indicates higher volatility, which could reflect investor uncertainty that may not be justified.

Sabra's strategic focus on acquisitions could position it well for growth despite current challenges.

Key Risk

If occupancy rates show a significant improvement, it could shift the market's perception of Sabra's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Sabra can recover from recent earnings misses and capitalize on growth opportunities in healthcare real estate.

Bull Confirmed If

Exceeding EPS of $0.17 and showing revenue growth above $219 million would confirm the bull case.

Bear Confirmed If

Falling short of the $0.17 EPS estimate and showing declining revenue would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±12.32%

Historical Avg

±1.2%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings announcement.

Options are pricing ±12.3% while SBRA has averaged ±1.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

19.8%

Calls (800)P/C Ratio: 0.18Puts (100)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Sabra beats expectations, history suggests the stock could rise by about 0.37%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating an average drop of 0.71% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on occupancy rates and any changes in tenant demand.
2Details on potential acquisitions or partnerships in the healthcare sector.
3Management's outlook on the healthcare market and economic conditions.
4Any changes to dividend policies or financial guidance.
5Insights into operational efficiencies and cost management strategies.